Rockwell Medical Technologies (RMTI) Reports In-Line Q1 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. FIX
9. TSCO
10. BE

Go back to Rockwell Medical Technologies (RMTI) Reports In-Line Q1 EPS

Rockwell Medical Reports First Quarter Results

May 9, 2017 4:01 PM EDT

WIXOM, Mich., May 09, 2017 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis, reported results for the quarter ended March 31, 2017.

Q1 2017 Financial Highlights

Sales were $14.6 million, or $1.0 million higher than Q1 2016, primarily due to higher domestic sales.Sequentially, sales increased approximately 9% over the fourth... More